HPV Immunization

Last Updated:

On This Page:

In 2016, 50.4% of females aged 13-15 years had received 2+ doses of the HPV vaccine.

Summary graph for HPV Immunization, Click to see detailed view of graph

See Graph Details

Introduction

Human papillomavirus (HPV) is a common virus that is spread through sexual contact. Some types of HPVs can cause genital warts, and other types, called high-risk or oncogenic HPVs, can cause cancer. High-risk HPVs cause virtually all cervical cancers, most anal cancers, and some vaginal, vulvar, penile, and oropharyngeal cancers. Many HPV infections go away on their own within 1 to 2 years. However, infections that last for many years increase a person’s risk of developing cancer.

HPV vaccines work like other immunizations (a technique used to cause an immune response that results in resistance to a specific disease) that guard against viral infections. HPV vaccines prevent the most common types of HPV that cause cancer and genital warts. The U.S. Food and Drug Administration has approved the use of Gardasil 9® to prevent cancers related to HPV. According to the Centers for Disease Control and Prevention (CDC), both males and females ages 9 through 26 years should get vaccinated.

Because the vaccines do not protect against all HPV infections that cause cervical cancer, it is important for vaccinated women to continue cervical cancer screening.

Measure

The percentage of adolescents who received 1+ dose, 2+ doses or 3+ doses of a HPV vaccine.

The National Immunization Survey Teen (NIS-Teen) vaccination coverage estimates are based on provider-reported vaccination histories from adolescents with adequate provider data (APD). NIS-Teen implemented a revised APD definition in 2014, thus estimates in 2014 and after are not directly comparable to those from prior years.  However, the change in APD definition does not impact overall vaccination coverage trends; vaccines routinely recommended during adolescence, such as HPV, were less affected than vaccines routinely recommended in childhood. Additional information on implementation of the revised APD definition and assessment of impact on vaccine coverage estimates are available at http://www.cdc.gov/vaccines/imz-managers/coverage/nis/teen/apd-report.html

Healthy People 2020 Target

  • Increase to 80 percent the proportion of females aged 13–15 years who have received at least three doses of HPV vaccine.

Healthy People 2020 is a set of goals set forth by the Department of Health and Human Services.
Note: Goals are indicated as blue line on Detailed Trend Graphs.

Data Source

Centers for Disease Control and Prevention, The National Immunization Surveys (NIS), 2008-2016.

Trends and Most Recent EstimatesHelp with navigating the graphs and data tables

Females

Ages 13-15
Percent of females aged 13-15 years who had received the human papillomavirus (HPV) vaccine by the number of vaccination dosages received, 2008-2016
Overview Graph Detailed Trend Graphs Most Recent Estimates (2016)
Percent 95% Confidence Interval
Thumbnail of graph for Percent of females aged 13-15 years who had received the human papillomavirus (HPV) vaccine by the number of vaccination dosages received, 2008-2016 1+ dosesClick to see the detailed trend graph for 1+ doses 62.1 59.8 - 64.4
2+ dosesClick to see the detailed trend graph for 2+ doses 50.4 47.9 - 52.9
3+ dosesClick to see the detailed trend graph for 3+ doses 37.2 34.8 - 39.6
Ages 13-17
Percent of females aged 13-17 years who had received the human papillomavirus (HPV) vaccine by the number of vaccination dosages received, 2008-2016
Overview Graph Detailed Trend Graphs Most Recent Estimates (2016)
Percent 95% Confidence Interval
Thumbnail of graph for Percent of females aged 13-17 years who had received the human papillomavirus (HPV) vaccine by the number of vaccination dosages received, 2008-2016 1+ dosesClick to see the detailed trend graph for 1+ doses 65.1 63.4 - 66.8
2+ dosesClick to see the detailed trend graph for 2+ doses 55.0 53.1 - 56.9
3+ dosesClick to see the detailed trend graph for 3+ doses 43.0 41.1 - 44.9

Males

Ages 13-15
Percent of males aged 13-15 years who had received the human papillomavirus (HPV) vaccine by the number of vaccination dosages received, 2012-2016
Overview Graph Detailed Trend Graphs Most Recent Estimates (2016)
Percent 95% Confidence Interval
Thumbnail of graph for Percent of males aged 13-15 years who had received the human papillomavirus (HPV) vaccine by the number of vaccination dosages received, 2012-2016 1+ dosesClick to see the detailed trend graph for 1+ doses 54.7 52.5 - 56.9
2+ dosesClick to see the detailed trend graph for 2+ doses 42.0 39.8 - 44.2
3+ dosesClick to see the detailed trend graph for 3+ doses 29.5 27.4 - 31.6
Ages 13-17
Percent of males aged 13-17 years who had received the human papillomavirus (HPV) vaccine by the number of vaccination dosages received, 2012-2016
Overview Graph Detailed Trend Graphs Most Recent Estimates (2016)
Percent 95% Confidence Interval
Thumbnail of graph for Percent of males aged 13-17 years who had received the human papillomavirus (HPV) vaccine by the number of vaccination dosages received, 2012-2016 1+ dosesClick to see the detailed trend graph for 1+ doses 56.0 54.3 - 57.7
2+ dosesClick to see the detailed trend graph for 2+ doses 43.6 41.9 - 45.3
3+ dosesClick to see the detailed trend graph for 3+ doses 31.5 29.9 - 33.1

Evidence-based Resources

State and local statistics on HPV vaccination and HPV knowledge can be used to prioritize cancer control efforts and are available on the State Cancer Profiles  website.  Locate evidence-based practices and population-based intervention approaches along with evidence-based interventions on the Cancer Control P.L.A.N.E.T. web portal.

Additional Information on HPV Immunization

For the public

For health professionals

Scientific reports

Statistics

Year Range

2008-2016

Recent Summary Trend Year Range

2012-2016

Summary Tables

HPV

Recent Summary Trend

Rising

Desired Direction

Rising